1. Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, Irccs, Milan, Italy
2. Department of Clinical and Molecular Medicine, Oncology Unit, “la Sapienza” University of Rome, Azienda Ospedaliera Sant’Andrea, Rome, Italy
3. Department of Medicine, University of Udine, Udine, Italy
4. Department of Oncology and Haematology, University of Milan, Milan, Italy
5. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA